Roots Analysis has done a detailed report on Global Bioreactors and Fermenters Market, covering key aspects of the industry and identifying future growth opportunities.
Key Market Insights
Presently, over 255 companies have the required expertise to manufacture various types of bioreactors and fermenters across the globe
The current market landscape is dominated by the presence of start-ups / small companies (up to 50 employees) and mid-sized companies (51-500 employees), which collectively represent over 90% of the total number of bioreactor and fermenter manufacturers.
Close to 80% firms manufacture bioreactors and fermenters for batch processes; of these, 55% of the manufacturers have the capability to scale-up their equipment from lab to commercial scale
The bioreactors and fermenters market landscape is fragmented; most of the well-established players are located in developed regions, while majority of small players are located in the Asia-Pacific region
The emergence of COVID-19 in the recent past led to a surge in demand for complex biologics and subsequently the requirement of novel bioreactors and fermenters; these developments prompted several bioreactor and fermenter manufacturers to upgrade their capabilities
The global installed bioreactors and fermenters capacity is distributed across various geographies; over 60% of this capacity is installed in the in-house facilities of biologics manufacturers
Stainless steel bioreactors hold a prominent share (~90%) of the current installed biomanufacturing capacity; majority of this is dedicated to the manufacturing of mammalian and microbial based therapeutics
The global bioreactors and fermenters market is likely to grow at a CAGR of ~11%, till 2035; the projected opportunity is likely to be driven by continuous manufacturing bioprocesses
In the long term, the disposable / single-use systems used for the manufacturing of antibodies and other novel biologics are likely to emerge as the key growth drivers of the overall market
Table of Contents
-
PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines -
EXECUTIVE SUMMARY
-
INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Bioreactors
3.3. Components of a Bioreactor
3.4. Types of Bioreactors
3.5. Applications of Bioreactors
3.6. Future Perspectives -
BIOREACTOR AND FERMENTER MANUFACTURERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Bioreactor and Fermenter Manufacturers: Overall Market Landscape -
COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Small Companies
5.5. Company Competitiveness Analysis: Mid-sized Companies
5.6. Company Competitiveness Analysis: Large and Very Large Companies -
COMPANY PROFILES
6.1. Chapter Overview
6.2. Applikon Biotechnology (Acquired by Getinge)
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Bionet
6.4. Cytiva
6.5. Eppendorf
6.6. Merck
6.7. Ollital Technology
6.8. Parr Instrument Company
6.9. Sartorius
6.10. Shanghai Bailun Biological Technology
6.11. Solaris Biotech
6.12. Solida Biotech
6.13. Zhengzhou Laboao Instrument Equipment (LABAO)
-
CAPACITY ANALYSIS
7.1. Chapter Overview
7.2. Key Assumptions and Methodology
7.3. Concluding Remarks -
CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS
8.1. Chapter Overview
8.2. Bioprocess Control Software: Overall Market Landscape
8.3. Bioprocess Control Software Developers: Overall Market Landscape
8.4. Upstream Controllers: Overall Market Landscape
8.5. Upstream Controller Developers: Overall Market Landscape
8.6. Downstream Controller Systems: Overall Market Landscape
8.7. Downstream Controller System Developers: Overall Market Landscape
- MARKET SIZING AND OPPURTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Forecast Methodology
9.3. Global Bioreactors and Fermenters Market (Historical, Base and Forecasted Scenario), 2017-
2035
-
CONCLUDING REMARKS
-
EXECUTIVE INSIGHTS
-
APPENDIX 1: TABULATED DATA
-
APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html
You may also be interested in the following titles:
Conjugation and Labeling Services Market
Bispecific Antibodies Market
global digital twins market
quantum computing in drug discovery services market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#bioreactorsandfermenters #bioreactorsandfermentersmarket #fermentation #fermentationbioreactors #bioreactorsandfermentersmarketsize
Drawbacks of conventional parenteral drug delivery systems have paved the way for the development of improved techniques and better drug administration devices.
Over the past few years, there has been an evident shift towards the self-administration of drugs / therapies. These self-injection devices facilitate the effective administration of therapeutics for the treatment of emergency and chronic conditions.
The “Autoinjectors: IP Landscape” report features an extensive study of the key intellectual property (IP) documents (featuring granted autoinjectors patents, patent applications and other documents), describing the various types of autoinjectors and their components that offer safety features and patient compliance during self-administration of drugs. The insights generated in this report have been presented across two deliverables, a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain.
The research includes detailed profiles of 10+ key players (listed below); the profiles feature an overview of the developer, its financial information (if available), product portfolio (under development / marketed) recent developments and an informed future outlook.
Bristol Myers Squibb
Sanofi
Ypsomed
Novo Nordisk
Owen Mumford
Becton Dickinson
Janssen
SHL Group
Amgen
Aptar Pharma
UCB
Meridian Medical
Eli Lilly
PHC technologies
Ascendis Pharma
Table of Contents
EXCEL DELIVERABLE
-
RESEARCH NOTES
-
SUMMARY DASHBOARD
-
OVERALL INTELLECTUAL PROPERTY LANDSCAPE DATASET
-
PRIOR ART SEARCH EXPRESSIONS (KEYWORD ANALYSIS)
-
PATENT APPLICATIONS DATASET
-
GRANTED PATENTS DATASET
-
CLAIMS ANALYSIS
-
KEY APPLICANTS ANALYSIS
-
CPC ANALYSIS
-
APPENDIX I: PIVOT TABLES
-
APPENDIX II: COUNTRY / GEOGRAPHY CODES
-
APPENDIX III: INNOVATION CATEGORIES
POWERPOINT DELIVERABLE
-
CONTEXT
-
PROJECT APPROACH
-
PROJECT OBJECTIVES
-
EXECUTIVE SUMMARY
-
INTRODUCTION
-
OVERALL INTELLECTUAL PROPERTY LANDSCAPE
-
KEY PRIOR ART SEARCH EXPRESSIONS
-
INTELLECTUAL PROPERTY VALUATION ANALYSIS
-
ANALYSIS OF PATENT APPLICATIONS
-
ANALYSIS OF GRANTED PATENTS
-
KEY APPLICANTS
-
POCKETS OF INNOVATION AND WHITE SPACES
-
FUTURE OUTLOOK
-
APPENDICES
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/autoinjectors-intellectual-property-landscape.html
You may also be interested in the following titles:
Global Antibiotics Market
Pharmaceutical Polymers / Medical Polymers Market
Global Gene Switch Market
Cell Therapy Media Market, Cell Therapy Kits Market, Cell Therapy Reagents Market and Cell Therapy Surface Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com